REG - Tata Steel Limited - Acquisition in Medica TS Hospital Pvt Ltd

TATA SteelAnnouncement

Mon 17:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260330:nRSd7026Ya&default-theme=true

RNS Number : 7026Y  Tata Steel Limited  30 March 2026

 

 

Ref: SEC/2226/2025-26

March 30, 2026

London Stock Exchange

London

 

Dear Madam, Sirs,

 

Sub:    Acquisition of entire stake in Medica TS Hospital Private Limited

 

This is further to our disclosure dated March 17, 2026 on the abovementioned
subject.

 

This is to inform you that, Tata Steel Limited ('Company') has today i.e. on
March 30, 2026, completed the acquisition of the following securities in
Medica TS Hospital Private Limited ('Medica TS Hospital'), a subsidiary
company, from Manipal Hospitals Eastern India Private Limited (formerly known
as Medica Hospitals Private Limited), as per the terms and conditions of the
Share Purchase Agreement executed on March 17, 2026, for an aggregate
consideration of ₹1.49 crore:

 

a)   7,40,000 equity shares of face value ₹10/- each, constituting 49%
equity stake in Medica TS Hospital; and

b)   2,30,05,182, - 0.01% Optionally Convertible Redeemable Preference
Shares ('OCRPS') constituting 31.85% of preference share stake of Medica TS
Hospital.

 

On completion of the aforesaid acquisition, Tata Steel Limited holds 100%
stake in equity shareholding and in OCRPS of Medica TS Hospital.  Medica TS
Hospital has become a wholly owned subsidiary of the Company.

 

This disclosure is being made by the Company in compliance with Regulations 30
and 51 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, as amended.

 

This is for your information and records.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACQURSNRNAUOOAR



            Copyright 2019 Regulatory News Service, all rights reserved